Main > ONCOLOGY (**) > Ovarian Cancer Pt-Sensitive R *** > Treatment > EU. I. PacliTaxel Inj.+Carboplatin

---

EU. I. PacliTaxel Inj.+Carboplatin's subsections
(*) EU Approval Date: 2018. 11.22
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 12.29.
PR Web-Site
TradeMark

EU. I. PacliTaxel Inj.+Carboplatin's products
This section has no products